ARUP's Laboratory Test Directory
| 0050779: Diphtheria, Tetanus, and H. Influenzae b Antibodies, IgG |
| Test Mnemonic: DTH | |
|
#ExistMethodology>
Methodology: Multi-Analyte Fluorescent Detection
*ExistMethodology> #ExistPerformed> Performed: Mon, Wed, Fri *ExistPerformed> #ExistReported> Reported: 1-4 days *ExistReported> |
| Specimen Required: | |
|
#ExistCollect>
Collect: One 4 mL SST.
*ExistCollect> #ExistTransport> Transport: 1.5 mL serum at 2-8°C. (Min: 0.7 mL) Submit specimen in an ARUP Standard Transport Tube. *ExistTransport> #ExistPedCollectTransport> Pediatric Collection/Transport: 0.45 mL serum at 2-8°C. *ExistPedCollectTransport> #ExistRemarks> Remarks: Acute and convalescent specimens must be labeled as such; parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. PLEASE CLEARLY MARK SPECIMENS "PRE-VACCINE" OR "POST-VACCINE" SO THAT SPECIMENS WILL BE SAVED AND TESTED SIMULTANEOUSLY. *ExistRemarks> #ExistConditions> Unacceptable Conditions: Plasma and other body fluids. Severely lipemic, contaminated, or hemolyzed specimens. *ExistConditions> #ExistStability> Stability: After separation from cells: Ambient: 2 days; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) *ExistStability> |
|
| Reference Interval: |
|
#ExistRefRange> Diphtheria and tetanus: Antibody concentration of > 0.1 IU/mL is usually considered protective for diphtheria or tetanus. Haemophilus influenzae type B: < 1.0 µg/mL = Antibody concentration not protective. > 1.0 µg/mL = Antibody to H. influenzae type B detected. Suggestive of protection. *ExistRefRange> |
| Interpretive Data: | |
|
#ExistInterpData>
Responder status is determined according to the ratio of a one-month, post-vaccination sample to pre-vaccination concentration of IgG antibodies as follows: Diphtheria and tetanus: 1. If the post-vaccination concentration is less than 1.0 IU/mL, the patient is considered a nonresponder. 2. If the post-vaccination concentration is greater than or equal to 1.0 IU/mL, a patient with a ratio of less than 1.5 is a nonresponder, and a ratio of 1.5 to less than 3.0 is a weak responder, and a ratio of 3.0 or greater is a good responder. 3. If the pre-vaccination concentration is greater than 1.0 IU/mL, it may be difficult to assess the response based on a ratio alone. A post-vaccination concentration above 2.5 IU in this case is usually adequate. Haemophilus influenza B: 1. If the post-vaccination concentration is < 3.0 µg/mL, the patient is considered to be a nonresponder. 2. If the post-vaccination concentration is 3.0 µg/mL, a patient with a ratio of 4 is a good responder, a ratio of 2-4 is weak responder, and a ratio of < 2 is considered a nonresponder. *ExistInterpData> |
| CPT Code(s): | |
| 86317 Diphtheria; 86317 Tetanus; 86317 H. influenzae |